In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-17 of 17 for your search:
Drug:  dutasteride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 50 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: AVO105948, NCT00363311

2.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 50 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 104274, NCT00375765

3.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 40 to 90
Sponsor: Pharmaceutical / Industry
Protocol IDs: AVO108943, NCT00470834

4.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Closed
Age: 35 to 90
Sponsor: Other
Protocol IDs: 047838, NCT00805701

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 45 to 80
Sponsor: Other
Protocol IDs: CURC/CUOG-AVIAS-0601, NCT00553878

6.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 50 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARI40006, NCT00056407

7.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CASE14804, GSK106046 (formerly 103988), NCT00244309

8.

Phase: Phase III
Type: Diagnostic
Status: Unknown
Age: 18 to 80
Sponsor: NCI
Protocol IDs: TJUH-06F-145, NCT00398281

9.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 01253 - Committee 1, FHCRC-05026, 05-8538-V 01, 28741-A, 01253, NCT00298155

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Adult
Sponsor: Other
Protocol IDs: CDR0000514492, RPCI-I-34904, NCT00403000

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 85
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARI109924, NCT00558363

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EH07-109, NCT00668642

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: 09-008, NCT00853697

14.

Phase: Phase II
Type: Treatment
Status: Unknown
Age: 80 and under
Sponsor: Other
Protocol IDs: UCL-09-0221, UCL-09/0221-MAPPED, MAPPED, EUDRACT-2009-012405-18, EU-21067, NCT01193855

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-448, NCT01393730

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MDV3100-07, NCT01547299

17.

Phase: No phase specified
Type: Diagnostic, Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: CDR0000596822, UCSF-05551, H7056-26910-03, 05551, GSK-UCSF-05551, NCT00706966
New Search